Medpace 

$339.38
115
+$3.64+1.08% Monday 20:00

統計

當日最高
342.56
當日最低
335.66
52週最高
459.77
52週最低
227.21
成交量
318,423
平均成交量
266,090
市值
11.01B
市盈率
33.45
股息收益率
-
股息
-

即將到來

收益

21Oct預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
1.8
2.27
2.73
3.2
預期每股收益
2.794971
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 MEDP 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

418.86$平均價格目標
最高估價為 $450。
來自過去 6 個月內的 8 個評級。這不是投資建議。
買入
75%
持有
25%
賣出
0%

關於

Commercial Services
Miscellaneous Commercial Services
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
首席執行官
August Troendle
員工
5800
國家
US
ISIN
US58506Q1094

上市公司